Universitätsfrauenklinik Ulm

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer2 trials
• Endometrial cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• AGO Research GmbH1 trial
• Grupo Español de Investigación en Cáncer de Ovario1 trial
• Karyopharm Therapeutics Inc1 trial
• University Hospital Tuebingen1 trial

Running trials

• Active, not recruiting

  Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

  NCT05611931· Phase 3· Karyopharm Therapeutics Inc· Source

• Recruiting

  Praegnant Breast Cancer: Early/Advanced/Metastatic

  NCT02338167· University Hospital Tuebingen· Source

  Contact: Erik Belleville, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting

Closed trials

• Completed

  Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

  NCT03598270· Phase 3· Grupo Español de Investigación en Cáncer de Ovario· Source

• Completed

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· Phase 3· AGO Research GmbH· Source